Literature DB >> 7942176

Current pattern of in-hospital aneurysmal rebleeds. Analysis of a series treated with individually timed surgery and intravenous nimodipine.

H J Steiger1, J Fritschi, R W Seiler.   

Abstract

The management of aneurysmal subarachnoid haemorrhage has recently changed considerably. Emergency admission to specialized centres and early surgery have become common practice. In addition, the use of nimodipine has gained widespread acceptance. Little data are available concerning the frequency and temporal profile of reruptures under the current policies. The case histories of 387 patients treated for aneurysmal subarachnoid haemorrhage between January 1984 and March 1992 were reviewed with regard to the incidence of in-hospital reruptures. All patients were managed according to the same protocol including a policy of individually timed early surgery and intravenous nimodipine. A total of 44 first in-hospital rebleeds were observed during the waiting period. Two percent of the patients admitted on the day of haemorrhage had a rebleed on the same day after admission to the hospital. No rebleeds were observed on the day after subarachnoid haemorrhage. Rebleed rates on day 2 and 3 were also low with 0.6 and 0.8% of the population with an unclipped aneurysm. For the following 10 days, the daily rate of rerupture increased. A further peak was observed during the 4th week. Using life-table methods, the cumulative rate of rebleeds was calculated as 23% within 2 weeks and 42% within 4 weeks. Although patients suffering rebleeds differed in several respects from patients without rebleeds, most of the differences could be identified to be a consequence of a selection bias resulting in a longer period of exposure to the risk of rerupture for certain subgroups. Only patients suffering a loss of consciousness after the initial subarachnoid haemorrhage were definitively exposed to a higher daily risk of rerupture.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7942176     DOI: 10.1007/bf01808541

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  21 in total

1.  Rebleeding from ruptured intracranial aneurysms.

Authors:  S Juvela
Journal:  Surg Neurol       Date:  1989-11

2.  Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations.

Authors:  H B Locksley
Journal:  J Neurosurg       Date:  1966-09       Impact factor: 5.115

3.  Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery.

Authors:  J Ohman; O Heiskanen
Journal:  J Neurosurg       Date:  1988-11       Impact factor: 5.115

4.  Outcome of aneurysmal subarachnoid hemorrhage in a hospital population: a prospective study including early operation, intravenous nimodipine, and transcranial Doppler ultrasound.

Authors:  R W Seiler; H J Reulen; P Huber; P Grolimund; U Ebeling; H J Steiger
Journal:  Neurosurgery       Date:  1988-11       Impact factor: 4.654

5.  Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study.

Authors:  N F Kassell; J C Torner
Journal:  Neurosurgery       Date:  1983-11       Impact factor: 4.654

6.  Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage.

Authors:  A Hijdra; J van Gijn; N J Nagelkerke; M Vermeulen; H van Crevel
Journal:  Stroke       Date:  1988-10       Impact factor: 7.914

7.  Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.

Authors:  K C Petruk; M West; G Mohr; B K Weir; B G Benoit; F Gentili; L B Disney; M I Khan; M Grace; R O Holness
Journal:  J Neurosurg       Date:  1988-04       Impact factor: 5.115

8.  A trial of the effect of nimodipine on outcome after head injury.

Authors:  I Bailey; A Bell; J Gray; R Gullan; O Heiskanan; P V Marks; H Marsh; D A Mendelow; G Murray; J Ohman
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

9.  Rebleeding of ruptured intracranial aneurysms in the acute stage.

Authors:  T Inagawa; K Kamiya; H Ogasawara; T Yano
Journal:  Surg Neurol       Date:  1987-08

10.  Nimodipine and early aneurysm operation in good condition SAH patients.

Authors:  L M Auer; L Brandt; U Ebeling; J Gilsbach; U Groeger; A Harders; B Ljunggren; F Oppel; H J Reulen; H Saeveland
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

View more
  5 in total

Review 1.  Rebleeding after aneurysmal subarachnoid hemorrhage.

Authors:  R M Starke; E S Connolly
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

2.  Aneurysmal rebleeding : factors associated with clinical outcome in the rebleeding patients.

Authors:  Ki Chul Cha; Jae Hoon Kim; Hee In Kang; Byung Gwan Moon; Seung Jin Lee; Joo Seung Kim
Journal:  J Korean Neurosurg Soc       Date:  2010-02-28

3.  Effect of rebleeding on the course and incidence of vasospasm after subarachnoid hemorrhage.

Authors:  A S Lord; L Fernandez; J M Schmidt; S A Mayer; J Claassen; K Lee; E S Connolly; N Badjatia
Journal:  Neurology       Date:  2011-12-14       Impact factor: 9.910

4.  Salvage of distal non-target coil embolization with stent placement and intravenous eptifibatide in a ruptured, unsecured, atypical aneurysm.

Authors:  Nazli Janjua; Sebina Bulic; Benedict C Tan; Kessarin Panichpisal; John Miller
Journal:  BMJ Case Rep       Date:  2013-03-27

Review 5.  Risk factors for rebleeding of aneurysmal subarachnoid hemorrhage: a meta-analysis.

Authors:  Chao Tang; Tian-Song Zhang; Liang-Fu Zhou
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.